Feature | Cristen C. Bolan

Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.

Home September 09, 2007
Home
News

September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...

Home September 09, 2007
Home
Feature | Melissa Allen

According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...

Home September 09, 2007
Home
News

September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...

Home September 09, 2007
Home
News

September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...

Home September 09, 2007
Home
Feature

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.

Home September 09, 2007
Home
Technology

Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...

Home September 06, 2007
Home
Technology

Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...

Home September 06, 2007
Home
Technology

Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.

Home September 06, 2007
Home
Technology

Siemens Automation and Drives (A&D) has added a 1MP color display to its portfolio of medical monitors. The SCD 19110 ...

Home September 05, 2007
Home
News

September 6, 2007 – The New England Journal of Medicine published the first study to demonstrate a clear superiority of ...

Home September 05, 2007
Home
Technology

Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...

Home September 05, 2007
Home
Technology

Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...

Home September 05, 2007
Home
News

September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.

Home September 05, 2007
Home
News

September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...

Home September 05, 2007
Home
Subscribe Now